Neural signatures of cognitive flexibility and reward sensitivity following nicotinic receptor stimulation in dependent smokers : a randomized trial by Lesage, Elise et al.
Neural Signatures of Cognitive Flexibility
and Reward Sensitivity Following Nicotinic Receptor
Stimulation in Dependent Smokers
A Randomized Trial
Elise Lesage, PhD; Sarah E. Aronson, BA; Matthew T. Sutherland, PhD; Thomas J. Ross, PhD; Betty Jo Salmeron, MD; Elliot A. Stein, PhD
IMPORTANCE Withdrawal from nicotine is an important contributor to smoking relapse.
Understanding how reward-based decisionmaking is affected by abstinence and by
pharmacotherapies such as nicotine replacement therapy and varenicline tartrate may aid
cessation treatment.
OBJECTIVE To independently assess the effects of nicotine dependence and stimulation of
the nicotinic acetylcholine receptor on the ability to interpret valence information (reward
sensitivity) and subsequently alter behavior as reward contingencies change (cognitive
flexibility) in a probabilistic reversal learning task.
DESIGN, SETTING, AND PARTICIPANTS Nicotine-dependent smokers and nonsmokers
completed a probabilistic reversal learning task during acquisition of functional magnetic
resonance imaging (fMRI) in a 2-drug, double-blind placebo-controlled crossover design
conducted from January 21, 2009, to September 29, 2011. Smokers were abstinent from
cigarette smoking for 12 hours for all sessions. In a fully Latin square fashion, participants in
both groups underwent MRI twice while receiving varenicline and twice while receiving a
placebo pill, wearing either a nicotine or a placebo patch. Imaging analysis was performed
from June 15, 2015, to August 10, 2016.
MAIN OUTCOME ANDMEASURES Awell-established computational model captured effects of
smoking status and administration of nicotine and varenicline on probabilistic reversal
learning choice behavior. Neural effects of smoking status, nicotine, and varenicline were
tested for onMRI contrasts that captured reward sensitivity and cognitive flexibility.
RESULTS The study included 24 nicotine-dependent smokers (12 women and 12men; mean
[SD] age, 35.8 [9.9] years) and 20 nonsmokers (10 women and 10men; mean [SD] age, 30.4
[7.2] years). Computational modeling indicated that abstinent smokers were biased toward
response shifting and that their decisions were less sensitive to the available evidence,
suggesting increased impulsivity during withdrawal. These behavioral impairments were
mitigated with nicotine and varenicline. Similarly, decreasedmesocorticolimbic activity
associated with cognitive flexibility in abstinent smokers was restored to the level of
nonsmokers following stimulation of nicotinic acetylcholine receptors (familywise
error–corrected P < .05). Conversely, neural signatures of decreased reward sensitivity in
smokers (vs nonsmokers; familywise error–corrected P < .05) in the dorsal striatum and
anterior cingulate cortex were not mitigated by nicotine or varenicline.
CONCLUSIONS AND RELEVANCE There was a double dissociation between the effects of
chronic nicotine dependence on neural representations of reward sensitivity and acute
effects of stimulation of nicotinic acetylcholine receptors on behavioral and neural signatures
of cognitive flexibility in smokers. These chronic and acute pharmacologic effects were
observed in overlappingmesocorticolimbic regions, suggesting that available
pharmacotherapies may alleviate deficits in the same circuitry for certain mental
computations but not for others.
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A lthough 70% of adult smokers want to quit smoking,1most attempts to quit fail within the first week.2 Ama-jor cause of relapse is the tobacco abstinence syn-
drome, characterized by deficits in cognitive, affective, and
reward processing.2-6 Like other drugs of abuse, nicotine en-
gages themesocorticolimbic (MCL) system,whichconsistspri-
marily of striatal and prefrontal brain areas targeted by mid-
braindopamine (DA)neurons.7,8Nicotine indirectly stimulates
DA neurons through agonist effects on nicotinic acetylcholine
receptors (nAChRs).9-13During thedevelopmentofnicotinede-
pendence,neuroplastic changesoccur throughout theMCLcir-
cuitry to downregulate levels of DA; drug administration be-
comesnecessarytoreachabaselinestate,whiledrugabstinence
leads to a hypodopaminergic withdrawal state.9,12-14
Mesocorticolimbic circuitry subserves reward-based de-
cisionmaking, and its dysregulation in early abstinence likely
contributes to relapse.15 Probabilistic reversal learning (PRL)
captures 2 crucial components of reward-baseddecisionmak-
ing:processing rewardingvspunishingoutcomes (reward sen-
sitivity), and deciding when to change one’s behavior in the
face of negative outcomes vs when to maintain a previous
choice (cognitive flexibility). In a PRL task, participants up-
date rewardcontingenciesbasedonuncertain informationand
adjust responses accordingly.16,17 This task relies on MCL
circuitry,18 which is modified by acute and chronic nAChR
stimulation.5,15,19-21However, howreward sensitivity andcog-
nitive flexibility are affected by the deficit state that charac-
terizes early abstinence and how such deficits may be miti-
gated by available pharmacotherapies remain unknown.
Probabilistic reversal learning is a promising measure of
cognitive flexibility and perseveration in addiction, with im-
paired performance in alcohol, cocaine, and amphetamine
dependence.22-27 Rodent studies indicate that chronic admin-
istrationof nicotine impairs cognitive flexibility during rever-
sal learning28,29 and that acute delivery of nicotine or vareni-
cline tartrate alleviateswithdrawal-induced reversal learning
deficits innicotine-dependent animals.30Despite relevance to
nicotine withdrawal and subsequent relapse, to our knowl-
edge, the interactingeffects ofnicotinedependenceandacute
stimulationofnAChRsonrewardsensitivityandcognitive flex-
ibility during PRL have not been characterized in humans.
Nicotine replacement therapy and varenicline, effective
smoking cessation treatments, stimulate α4β2nAChRs.Nico-
tine is a full agonist at these nAChRs, and varenicline is a par-
tial agonist at these receptors, partiallymimicking the effects
of nicotine in its absence while blunting the effects of nico-
tine in its presence.31 Although the interacting effects of nico-
tine and varenicline have been characterized at the receptor
level, it isunknownhowthesedrugsactand interactonreward-
baseddecisionmakingand itsneural signatures.Here,weused
functional magnetic resonance imaging (fMRI) in abstinent
smokers and matched nonsmokers during PRL task perfor-
mance following administration of nicotine, varenicline, nei-
ther, or both. We could, therefore, independently assess the
effects of acute stimulation of nAChRs between a group of
chronicallyexposednicotine-dependentparticipants (withpu-
tativeneuroplastic circuit alterations) vs a groupof nonsmok-
ers. We applied a well-established computational model27,32
to participants’ choices to elucidate nicotinic effects on deci-
sion making. Given previous research, we hypothesized that
behavioral and neural indices of reward sensitivity and cog-
nitive flexibility would be reduced in abstinent smokers. We
also expected that acutely abstinent smokers’ deficits would
be alleviated by stimulation of nAChRs, consistent with allo-
static models of addiction.12-14 Lastly, we expected that the
effects of nicotine and varenicline on behavior and brain
indices would reflect their interacting effects at the nAChR
level.31
Methods
Participants
Twenty-four cigarette smokers (nicotine-dependent adults
smoking ≥10 cigarettes daily for >2 years; 12 women and 12
men) and 20 nonsmokers (adults with no smoking history
within the past 2 years and no lifetime daily cigarette use of
>1 month; 10 women and 10 men) were recruited at the
National Institute on Drug Abuse–Intramural Research Pro-
gram in Baltimore, Maryland. All 44 participants were right-
handed, between 18 and 55 years of age, and healthy, with
no reported history of neurologic or psychiatric disorders,
contraindications to MRI, or drug dependence (except nico-
tine in the smokers). Written informed consent was
obtained in accordance with the National Institute on Drug
Abuse–Intramural Research Program Institutional Review
Board.
Experimental Design
The randomized, double-blind, placebo-controlled, cross-
overdesign involved2drugs: vareniclinepills (Chantix; Pfizer)
and nicotine patches (NicoDerm CQ; GlaxoSmithKline) (Trial
Protocol in Supplement 1). Participants completed6 fMRI ses-
sions; we report data from the 4 completely counterbalanced
sessions conducted from January 1, 2009, to September 29,
2011, crossing factorsNICOTINEandVARENICLINE (eAppen-
dix 1 and eFigure 1 in Supplement 2). Participants performed
multiple tasks5,6,33-35; here, we report PRL data.
Key Points
Question How are reward sensitivity and cognitive flexibility in
themesocorticolimbic system affected by acute abstinence and
stimulation of the nicotinic acetylcholine receptors in dependent
smokers?
Findings This placebo-controlled crossover study found a double
dissociation between decreased neural signatures of reward
sensitivity, which are associated with severity of nicotine
dependence but not with the acute effects of nicotine or
varenicline tartrate, and behavioral and neural signatures of
cognitive flexibility, which were impaired in the abstinent state but
restored with stimulation of the nicotinic acetylcholine receptors.
Meaning Currently available pharmacotherapies appear to
alleviate abstinent smokers’ impaired cognitive flexibility but not
reward sensitivity.
Cognitive Flexibility Following Nicotinic Receptor Stimulation Original Investigation Research
jamapsychiatry.com (Reprinted) JAMAPsychiatry June 2017 Volume 74, Number 6 633
© 2017 American Medical Association. All rights reserved.
Downloaded From: http://jamanetwork.com/pdfaccess.ashx?url=/data/journals/psych/0/ by a University of Gent / UZGent Kenniscentrum User  on 06/06/2017
PRL Task
Participants completed an event-related PRL task (eAppen-
dix 1 and eFigure 2 in Supplement 2) based on previous
studies.17,36,37 Participants aimed tomaximizemonetary gain
by learning which of 2 cues had a high probability (75%) of a
$1 reward and a low probability (25%) of a $1 loss, and which
cue had the opposite contingencies. After 5 consecutive cor-
rect choices or 20 trials, the contingencies were reversed un-
beknownst to the participants, who were required to shift
responses accordingly. Each scanning session (approximately
35minutes) consistedof three 120-trial runs. Functional (1104
whole-brain echoplanar imaging scans; repetition time, 2 sec-
onds; echo time, 27 milliseconds) and structural T1-weighted
brain images were acquired on a 3-T MRI scanner (3T
Siemens Magnetom Allegra) (eAppendix 1 in Supplement 2).
Behavioral Measures
We calculated PRL metrics based on previous work22,38: lose-
shift (probability of shifting a response following a loss),
win-stay (probability of repeating a response following a
win), trials to criterion (mean number of trials after reversal
before the participant selected the correct stimulus 5 times
consecutively), and number of perseverative errors (selecting
the previously rewarded cue at least 3 times following 2
losses after a reversal). We carried out mixed linear models
(random intercept) with GROUP as a between-participant
factor (smoker vs nonsmoker) and NICOTINE (nicotine vs
placebo) and VARENICLINE (varenicline vs placebo) as
within-participant factors. We used generalized (binomial
dependent variables) and general (continuous dependent
variables) mixed models in R using packages afex and phia
(https://www.r-project.org/). Interactioneffectsor trends in the
omnibus analysis were followed bywithin-group analyses.
Computational Modeling
Weappliedacomputationalmodelingapproachpreviouslyvali-
dated for PRL.32 Three models were fit: a Rescorla-Wagner
model,39and2HiddenMarkovModels,whichhavebeenshown
to better fit PRL behavior27,32,40 because they capture a cru-
cial task characteristic, namely, that the values of the cues are
each other’s inverse (ie, learning that cue A predicts a reward
entails learning that cue B predicts a punishment). Effects of
GROUP, NICOTINE, and VARENICLINE on free model para-
meters were analyzed as for the behavioral measures.
Imaging Analysis
Imaging analyses were carried out from June 15, 2015, to Au-
gust 10, 2016, inAnalysis of FunctionalNeuroImages (AFNI)41
using standard preprocessing and first-level modeling (eAp-
pendix 1 in Supplement 2). Four event types of interest were
modeled (win-stay, lose-stay, and lose-shift), as in previous
work.42Twocontrasts of interestwere calculated: reward sen-
sitivity (reward minus punishment) by subtracting lose-stay
trials fromwin-stay and cognitive flexibility (shiftminus stay)
by subtracting lose-stay from lose-shift trials (eAppendix 1 in
Supplement 2).
Mean activity patterns for reward sensitivity and cogni-
tive flexibility were computedwith 2-tailed t tests on partici-
pants’ beta maps (averaged over sessions). Results were cor-
rected for whole-brain familywise error (α < .05, voxelwise
P < .001, cluster size 19 voxels).
Group and drug effects for both contrasts of interest were
examined with mixed analyses of variance (between-
participant factor GROUP and within-participant factors
NICOTINE and VARENICLINE). Significant GROUP inter-
actions were followed by within-group analyses using
NICOTINE and VARENICLINE as factors. Given our a priori
hypothesis that group and pharmacologic effects would be
present in MCL areas, we applied a familywise error correc-
tion (α < .05) within a composite mask of interest consisting
of the bilateral nucleus accumbens, the caudate, the puta-
men, the amygdala, the bilateral anterior insula (AI), the
anterior cingulate cortex (ACC), and the orbitofrontal cortex
(1978 voxels in mask, voxelwise P < .05, cluster size 53 voxels
[eFigure 3 in Supplement 2]).
Results
Behavioral Measures
Completedemographicandbehavioraldataaregiven ineTables
1 and 2 in Supplement 2; checks for pharmacologic effective-
ness, order effects, and task engagement are in eFigures 4, 5,
and 6 in Supplement 2. One participant’s data were removed
fromall analysesowing topoordataquality.Becausenonsmok-
ers were younger (mean [SD] age, 30.4 [7.2] years) than smok-
ers (mean [SD] age, 35.8 [9.9] years;P = .04), agewas included
as a covariate when comparing groups in all behavioral and
imaging analyses.
Lose-shift probability (Figure 1A) showed significant
NICOTINE (χ21 = 3.79;P = .05) andGROUP × VARENICLINEef-
fects (χ21 = 4.89; P = .022), driven by NICOTINE (χ21 = 3.99;
P =.05)andVARENICLINE(χ21 = 7.78;P = .006)effects in smok-
ers and their absence amongnonsmokers.Win-stay probabil-
ity (Figure 1B) showedGROUP × NICOTINE (χ21 = 5.17;P = .04),
GROUP × VARENICLINE (χ21 = 9.136;P = .003), andNICOTINE
× VARENICLINE (χ21 = 6.80; P = .02) interactions. Abstinent
smokers stayed less after awincomparedwithwhen theywere
administered nicotine (χ21 = 7.84; P = .01) or varenicline
(χ21 = 8.53;P = .007),while nonsmokers receiving varenicline
stayed less after a win (χ21 = 5.29; P = .02). Varenicline effects
on trials to criterion (Figure 1C) differed between groups
(χ21 = 4.41;P = .04),whereby smokers receivingvarenicline re-
quired fewer trials (χ21 = 6.08; P = .02); neither drug affected
nonsmokers. Finally, there was a NICOTINE × VARENICLINE
interaction on the number of perseverative errors (Figure 1D;
χ21 = 7.65;P = .01). Counterintuitively, abstinent smokersmade
more perseverative errorswhen receiving nicotine (χ21 = 7.65;
P = .01) or varenicline (χ21 = 11.01; P = .002) than when they
were abstinent. Nonsmokers again showednobehavioral dif-
ferences following any drug manipulation.
Computational Modeling
Thebest-fittingmodelwasaHiddenMarkovModelwith4 free
parameters (Hidden Markov Model 2; eAppendices 1 and 2,
eTables 3-5, eFigures 7 and 8 in Supplement 2): bias toward
Research Original Investigation Cognitive Flexibility Following Nicotinic Receptor Stimulation
634 JAMAPsychiatry June 2017 Volume 74, Number 6 (Reprinted) jamapsychiatry.com
© 2017 American Medical Association. All rights reserved.
Downloaded From: http://jamanetwork.com/pdfaccess.ashx?url=/data/journals/psych/0/ by a University of Gent / UZGent Kenniscentrum User  on 06/06/2017
staying(alpha), inverse temperature (beta),whichcapturessen-
sitivity to available evidence, perceivedprobability of a rever-
sal (delta), andperceived increasedchanceofa reversal asmore
trials takeplace since the last reversal (delay-weight;Figure2).
Bias tostay(Figure2A)wassignificantlyaffectedbyGROUP,
NICOTINE,andVARENICLINE(3-wayinteraction:χ21 = 6.68;P =
.004),drivenby thepartial agonistNICOTINE × VARENICLINE
interaction in smokers: strong independent effects of nicotine
(χ21 = 19.88;P < .001) andvarenicline (χ21 = 11.28;P = .002), but
no significant effects in combination. That is, abstinent smok-
ers were biased toward shifting (ie, alpha <0.5), but nicotine-
satedsmokerswerebiased towardstaying (alpha>0.5). Inverse
temperature (Figure 2B) showed NICOTINE (χ21 = 10.86; P =
.005), VARENICLINE (χ21 = 4.36; P = .03), and NICOTINE ×
VARENICLINE effects (χ21 = 13.32; P < .001) across groups.
Abstinent smokers’ decisions were less sensitive to available
evidence, andrelianceonevidence increasedwithnicotine (χ21
= 9.94;P = .003)orvarenicline (χ21 = 9.57;P = .004).Transition
probability (Figure 2C) showed a GROUP × VARENICLINE ef-
fect (χ21 = 6.26;P = .02), driven by a reducedperceived transi-
tionprobability in smokers receivingvarenicline (χ21 = 6.12;P =
.01).Finally,delay-weight (Figure2D),whichreflectshowmuch
participants consider that contingencies regularly reverse,
showedanoverall NICOTINE trend (χ21 = 3.32;P = .07), driven
by abstinent smokers,whoweighted the time since last rever-
sal less (χ21 = 4.48; P = .045).
Imaging Results
Reward Sensitivity (Win-Stay − Lose-Stay)
Across sessions, the ventromedial prefrontal cortex, poste-
rior cingulate cortex, bilateral nucleus accumbens, putamen,
caudate, left intraparietal sulcus, bilateral secondary visual
cortex, and right cerebellum responded more to rewards
than punishments (Figure 3A and eTable 6 in Supplement 2).
Conversely, salience network areas (dorsal ACC [dACC] and
AI) were more active when processing punishments than
rewards, consistent with previous work.5,15,19-21
Effects of GROUP, NICOTINE, and VARENICLINE were
assessed within the a priori region-of-interest mask
(Figure 4A and B, and eTable 6 in Supplement 2). Smokers
showed significantly lower reward sensitivity than did non-
smokers in the dACC and dorsal striatum, extending into the
right amygdala. Unexpectedly, reward sensitivity was not
modulated by nicotine or varenicline. However, consistent
with a chronic effect of nicotine dependence, regression
weights in abstinence (taking a placebo pill and wearing a
placebo patch) correlated negatively with addiction severity
in smokers (assessed with the Fägerstrom Test for Nicotine
Dependence43; Figure 4C).
Cognitive Flexibility (Lose-Shift − Lose-Stay)
Across sessions, the dACC, bilateral AI, superior frontal
gyrus, superior parietal lobule, caudate, putamen, primary
Figure 1. Performance on the Probabilistic Reversal Learning Task as a Function of Smoking Group and Nicotinic Manipulation (Nicotine and
Varenicline Tartrate)
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A, Acutely abstinent smokers were more likely to shift responses following a
loss (lose-shift choice) compared with smokers who receive nicotine or
varenicline, while neither drug affected lose-shift behavior in nonsmokers.
B, Smokers receiving nicotine or varenicline repeated responses after a win
(win-stay choices) more than acutely abstinent smokers. Nonsmokers receiving
varenicline showed a decrease in win-stay choices. C, Smokers receiving
varenicline required fewer trials to reach criterion than smokers not receiving
varenicline. Nicotine did not affect trials to criterion in smokers, and neither
drug had an effect in nonsmokers. D, Acutely abstinent smokers made fewer
perseverative errors than smokers receiving either nicotine or varenicline.
Neither nicotine nor varenicline affected perseverative errors in nonsmokers.
Varenicline was given as varenicline tartrate. For an explanation of lose-shift and
win-stay, see the Behavioral Measures subsection of theMethods section. Error
bars indicate SEM.
a P < .05.
bP < .01.
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visual cortex, and cerebellumweremore active before a shift
than before repeating the same response following a negative
outcome (Figure 3B and eTable 7 in Supplement 2).
Althoughtherepeated-measuresanalysisofvariancewithin
our region-of-interest volume showednomainGROUPeffect,
there were significant NICOTINE and GROUP × NICOTINE
Figure 2. Model Parameters for the HiddenMarkovModel as a Function of Smoking Group and Nicotinic ReceptorManipulation (Nicotine and
Varenicline Tartrate)
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A, Acutely abstinent smokers were biased toward shifting responses
(alpha < 0.5), and this bias to shift was remedied with nicotine and varenicline.
Nonsmokers showed no bias. B, When smokers received nicotine or varenicline,
their choice behavior was more sensitive to the available evidence (higher
inverse temperature) compared with acute abstinence from nicotine. Neither
drug affected inverse temperature in nonsmokers. C, Smokers receiving
varenicline perceived the probability of a reversal to be lower than smokers
receiving a placebo pill. Neither nicotine nor varenicline affected transition
probability in nonsmokers. D, Smokers with a placebo patch took the time since
the last reversal into account less than smokers with a nicotine patch, while
varenicline did not affect this measure. Nonsmokers’ ability to factor in the time
since the last reversal was not affected by either drug. Error bars indicate SEM;
sqrt, square root.
a P < .05.
bP < .01.
c P < .001.
Figure 3.Whole-Brain Activation to Reward Sensitivity and Cognitive Flexibility Contrasts Across Groups and Conditions
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A, Increased activation to positive vs negative outcomes in the ventromedial
prefrontal cortex, posterior cingulate cortex, and ventral and dorsal striatum, as
well as the superior frontal gyrus and left cerebellum. Activity decreases in
anterior insula (AI), and the dorsal anterior cingulate cortex (dACC; warm colors
[positive t values]: reward > punishment; cool colors [negative t values]:
punishment > reward). B, Activation was greater preceding a shift than a stay in
the AI, dACC, dorsal striatum, dorsolateral prefrontal cortex, posterior parietal
cortex, occipital cortex, and cerebellum. Radiologic convention: left side of the
image is the right side of the brain. Threshold levels have been increased to
P < .00001 (A) and P < .0001 (B) with a cluster size of 70 voxels to allow for a
better visualization of the results (see eFigure 9A and 9B in Supplement 2 for
results corrected at familywise error–corrected P < .05). The x and y refer to the
location of the slices in the Talairach coordinate system; and the t refers to the t
value.
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effects. The follow-up within-group repeated-measures
analysis of variance for smokers showed that flexibility-
associated activity in the bilateral ventral and dorsal stria-
tum, bilateral AI, ventromedial prefrontal cortex, and dACC
was downregulated in abstinence, yet restored with adminis-
tration of nicotine (Figure 5 and eTable 7 in Supplement 2).
In all except the ventromedial prefrontal cortex cluster,
extracted regression weights correlated significantly with the
Figure 4. Lower Reward Sensitivity Activity in Smokers Than in Nonsmokers
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A, Group differences (smokers vs nonsmokers) in reward sensitivity in the
bilateral dorsal striatum and dorsal anterior cingulate cortex (dACC) within the a
priori volume of interest (familywise error–corrected P < .05). Radiologic
convention: left side of the image is the right side of the brain. B, Regression
weights extracted from the clusters identified in the imaging analysis; error bars
indicate the SEM (plotted to aid interpretation only—no statistical inference
should be drawn), and the shaded region indicates 95% CI. See eFigure 10 in
Supplement 2 for regression weights separating out wins and losses. C, Reward
sensitivity contrast weight in the absence of nicotine and varenicline tartrate
was associated with severity of nicotine dependence (Fägerstrom Test for
Nicotine Dependence [FTND] score). PUN indicates punishment, and REW,
reward.
Figure 5. Nicotine Effects on Cognitive Flexibility Contrast in Smokers
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A, Acute nicotine administration in smokers increases neural signatures of
cognitive flexibility in the bilateral striatum, anterior insula (AI), dorsal anterior
cingulate cortex (dACC), and ventromedial prefrontal cortex (vmPFC) within a
priori masked regions of interest (familywise error–corrected P < .05).
Radiologic convention: left side of the image is the right side of the brain.
B, Regression weights extracted from the clusters in part A show that activity is
reduced in acute abstinence and restored to the level of nonsmokers (shaded
band) when nicotine is administered. Although no significant varenicline
tartrate main effects or interactions were identified in the imaging contrast,
patterns are in line with the interaction of nicotine and varenicline at the
receptor level. Error bars indicate SEM (plotted to aid interpretation only—no
statistical inference should be drawn). Shaded regions indicate themean [SEM]
of the nonsmokers’ bold responses averaged across conditions. LST indicates
lose-stay; LSW, lose-switch; and rACC, rostral anterior cingulate cortex.
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bias to shift (α) in our computational model (eFigure 11 in
Supplement 2). Although not significant, the pattern of ex-
tracted regressionweights is consistent with varenicline par-
tial agonist effects (Figure 5B). No effects of either drug were
found among nonsmokers.
Discussion
Chronicexposure tonicotineandsubsequentdependence lead
to changes in MCL circuitry, which governs reward appraisal
and reward-based decision making.14,44 Understanding how
abstinence and pharmacotherapies such as nicotine replace-
ment therapy and varenicline affect these core MCL func-
tions can inform smoking cessation treatment. Using compu-
tationalmodelingandfMRI inaPRLtask,wefoundthatacutely
abstinent smokers were excessively flexible (biased to shift
their choice) and that neural activity in MCL areas (ACC, bi-
lateral striatum, andAI)was reducedbefore abehavioral shift.
Acuteadministrationofnicotineandvarenicline restored these
neural and behavioral deficits to levels comparable to those
in nonsmokers. In a double-dissociation fashion, smokers’
lower reward sensitivity in the dorsal striatum and dACCwas
not alleviated following stimulation of the nAChRbutwas as-
sociated with severity of dependence.
Reversal of Abstinent Smokers’ Increases in Impulsive
ChoiceWith nAChR Stimulation
Behavioral results showed that stimulation of the nAChRs af-
fectedPRL insmokersbutnot innonsmokers.Abstinent smok-
ers committed fewerperseverativeerrors andweremore likely
to shift followinga loss comparedwithwhen theywere receiv-
ingnicotineorvarenicline.Counterintuitively,perseverativeer-
rors and lose-shift probabilities among abstinent smokers re-
sembled those among nonsmokers. However, because of the
probabilistic tasknature, “perseverative”behavior isnot intrin-
sicallygoodorbad: consistently shifting followinga loss is sub-
optimal but counts as a flexible response. In contrast, compu-
tationalmodels cancapturehowtheaccumulationofevidence
informsstayingorshifting.UsingapreviouslyvalidatedHidden
MarkovModel,27,32 we found that abstinent smokers were bi-
ased toward shifting their responses (alpha) and relied less on
theavailableevidence(beta); that is,abstinentsmokersappeared
tomakemore impulsive, rash decisionswhen facing negative
outcomes. This deficit was remedied by stimulation of the
nAChR,wherebynicotineandvarenicline interactedconsistent
with their known pharmacologic actions at α4β2 receptors.31
Effects of Nicotine Dependence on Reward Sensitivity
in the Bilateral Dorsal Striatum and dACC
Dependent smokers had lowerneural responses to rewards in
theACCandbilateral dorsal striatum.Although somepreclini-
cal evidence shows nicotine-induced reward sensitization,45
our findings are consistent with a large body of evidence in-
dicating blunted striatal and medial prefrontal responses to
monetaryandnatural rewards in cocainedependence46,47 and
nicotinedependence.19,48,49Strikingly, theobserveddeficitwas
notmodulatedbyadministrationofnicotineorvareniclinebut
wasassociatedwithseverityof addiction.Theabsenceofacute
nicotinic effects is somewhat discrepant with previously re-
porteddifferences in rewardsensitivitybetweenabstinentand
sated smoking conditions.19,50 However, these studies ob-
served differences in cue reactivity or reward anticipation,
while our contrast focused on reward receipt. Rose et al51 re-
ported lowerMCL activity upon reward receipt in smokers vs
nonsmokers,whichwasnot remediedbynicotine butwas as-
sociatedwith years of smoking. Conversely, in amonetary in-
centive task, reduced rewardanticipation in smokerswasmiti-
gated with nicotine.19 Therefore, there may be a relevant
distinction between neural responses to reward-associated
cues (anticipation) and neural responses to actual reward re-
ceipt, whereby reductions in the former can be remedied by
acute stimulation of the nAChRs, while the latter are associ-
ated with severity of nicotine dependence. Reduced reward
sensitivitymay contribute to relapse, especially early in a quit
attempt. With prolonged abstinence, the availability of DA at
the receptor level normalizes,52 so future studies should as-
sess whether reward sensitivity is restored over time.
Acute Nicotinic Effects on Neural Correlates
of Cognitive Flexibility in Smokers’ MCL System
In stark contrast to rewardsensitivity,neural signaturesof cog-
nitive flexibility were modulated by acute administration of
nicotine (and to some extent varenicline). As hypothesized,
neural activity preceding a behavioral changewas reduced in
abstinent smokers throughout the MCL circuitry: the bilat-
eral ventral anddorsal striatum, the bilateral AI, theACC, and
the ventromedial prefrontal cortex (areas implicated in rein-
forcement learning and rule switching).53-55 When smokers
wore a nicotine patch, activity in these areas appeared to nor-
malize, reaching levels comparable to those observed among
nonsmokers. Thus, our results support an allostatic account
of addiction,wherebychronic exposure tonicotine leads to re-
ducedDA levels in abstinence,which are normalized through
stimulation of the nAChRs.14 Results also dovetail with pre-
clinical studies demonstrating reversal learning deficits ac-
companied by dorsal striatal brain-derived neurotrophic fac-
tordifferences innicotine-dependentrodents,29andalleviation
of such deficits with nicotine and varenicline.30 Specifically,
the findings of Jackson et al30 closely trackwith our results in
humans; these authors demonstrated PRL performance de-
creases in acutely abstinent nicotine-dependent rats, which
were alleviated by administration of nicotine and vareni-
cline,while findingnoeffectsofnicotineorvareniclineonPRL
performance in nicotine-naive rats.
Compulsivity, Excessive Flexibility, and DA Levels
Reversal learning is increasingly used to characterize
compulsive disorders, including dependence on alcohol,
cocaine, and amphetamines, as well as gambling and binge
eating.22-26,54,56,57However, PRLdeficits arenot alwaysdriven
byperseverationor inflexibility; inoursample,abstinentsmok-
ers shifted responses excessively. Similar excessive flexibility
has been documented in binge-eating disorder and cocaine
dependence,22,27,54 but cocaine, alcohol, and amphetamine
dependence have been linked to decreased flexibility.22,24,25
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Very fewstudieshave investigated state effects (abstinencevs
satiety) on reversal learning independentpopulations. Proba-
bilistic reversal learning studies in nondependent popula-
tions indicate that the effects of DA agonists crucially depend
on baseline DA levels,58,59 with dopaminergic manipulations
improving performance in individuals with low baseline lev-
els of DA but impairing performance in those with high base-
line levels of DA. The interacting chronic and acute effects of
nicotineexposure foundherecanbe interpreted in lightof low-
ered tonic DA levels in drug dependence13,50 and increases in
DA following drug administration. Our data are in line with
clinical and preclinical work showing abstinence-associated
behavioral deficits in reward responsivity in nicotine-
dependent individuals60 and complement results of previ-
ous neuroimaging studies showing that nicotine and vareni-
cline can mitigate the effects of abstinence on the limbic
system33,34 and can influence reward processing.5
Limitations
Ourstudyhassome limitations.First,weadministeredonly the
standardclinicaldosesofnicotineandvarenicline.Althoughre-
sults canbegeneralized tocurrent clinical applicationsofnico-
tine replacement therapy andvarenicline, different dosesmay
yield different effects. Future studies might explore dose-
responseeffectson reward-baseddecisionmakingand itsneu-
ral correlates. For example, larger nicotine doses in nonsmok-
ers may affect performance, although at the cost of adverse
effects.61 Second, we did not identify significant nicotine-by-
varenicline interactionson thecognitive flexibilityneuroimag-
ingcontrast,butextractedparametervalues trendedtowardthe
hypothesized nicotine-by-varenicline interaction. This find-
ing may indicate that our analysis was insufficiently powered
todetectsmaller (partialagonist)vareniclineeffects,while itdid
detect larger (full agonist) nicotine effects.
Conclusions
This is the first study, to our knowledge, investigating the ef-
fects of chronicnicotineexposureandacute stimulationof the
nAChRsonbrain andbehavioralmetricsduring reversal learn-
ing. We identified behavioral and MCL signatures of dys-
regulatedcognitive flexibility inabstinentsmokers,whichwere
restoredwithnicotine (and toa lesser extentvarenicline).Con-
versely, smokers’ lower neural response to reward was asso-
ciated with severity of dependence and not remedied with
nAChR stimulation. Thus,we found adouble dissociation be-
tween chronic and acute effects of nicotine on reward sensi-
tivity and cognitive flexibility within overlapping MCL
regions.Thisstudyhighlights theneedtodissociateacutedrug-
associated effects from effects associated with chronic drug
dependence, and to consider both mental computations and
their anatomical substrate. Finally, the results provide a neu-
ral basis for the efficacy of nicotine replacement therapy and
varenicline as smoking cessation tools, particularly associ-
ated with cognitive flexibility.
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